{"related:Z2Dq3M1eceAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","url":"https://www.nature.com/articles/nature14011?page=1","authors":["RS Herbst","RS Herbst JC Soria","RS Herbst JC Soria M Kowanetz","RS Herbst JC Soria M Kowanetz GD Fine","RS Herbst JC Soria M Kowanetz GD Fine O Hamid…"],"year":2014,"numCitations":3082,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4836193/","citationUrl":"http://scholar.google.com/scholar?cites=16172811975131816039&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Z2Dq3M1eceAJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16172811975131816039&hl=en&as_sdt=0,5","publication":"nature.com","p":1,"exp":1596879364517},{"title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","url":"https://www.nature.com/articles/nature13954?page=4","authors":["PC Tumeh","PC Tumeh CL Harview","PC Tumeh CL Harview JH Yearley","PC Tumeh CL Harview JH Yearley IP Shintaku…"],"year":2014,"numCitations":3357,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246418/","citationUrl":"http://scholar.google.com/scholar?cites=8600773541923439091&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:88Hsr_cVXHcJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8600773541923439091&hl=en&as_sdt=0,5","publication":"nature.com"},{"title":"Safety, activity, and immune correlates of anti–PD-1 antibody in cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1200690","authors":["SL Topalian","SL Topalian FS Hodi","SL Topalian FS Hodi JR Brahmer…"],"year":2012,"numCitations":9290,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1200690","citationUrl":"http://scholar.google.com/scholar?cites=10859371970938450815&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:f7Oeq0U9tJYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10859371970938450815&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","url":"https://www.nature.com/articles/nature13904?page=11","authors":["T Powles","T Powles JP Eder","T Powles JP Eder GD Fine","T Powles JP Eder GD Fine FS Braiteh","T Powles JP Eder GD Fine FS Braiteh Y Loriot…"],"year":2014,"numCitations":1829,"pdf":"http://sys.91sqs.net/mobilenews/pdfs/%E6%8A%97PD-L1%E6%8A%97%E4%BD%93MPDL3280A%E5%85%B7%E6%9C%89%E4%B8%B4%E5%BA%8A%E6%B2%BB%E7%96%97%E8%BD%AC%E7%A7%BB%E6%80%A7%E8%86%80%E8%83%B1%E7%99%8C%E7%9A%84%E7%96%97%E6%95%88.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7438817963127421284&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ZDkBYYb9O2cJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7438817963127421284&hl=en&as_sdt=0,5","publication":"nature.com"},{"title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti–PD-1 therapy","url":"https://clincancerres.aacrjournals.org/content/20/19/5064.short","authors":["JM Taube","JM Taube A Klein","JM Taube A Klein JR Brahmer","JM Taube A Klein JR Brahmer H Xu","JM Taube A Klein JR Brahmer H Xu X Pan…"],"year":2014,"numCitations":1623,"pdf":"https://clincancerres.aacrjournals.org/content/clincanres/20/19/5064.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7809835585382957626&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:OsL0LBYcYmwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7809835585382957626&hl=en&as_sdt=0,5","publication":"AACR"},{"title":"Pembrolizumab for the treatment of non–small-cell lung cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1501824","authors":["EB Garon","EB Garon NA Rizvi","EB Garon NA Rizvi R Hui","EB Garon NA Rizvi R Hui N Leighl…"],"year":2015,"numCitations":3642,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1501824","citationUrl":"http://scholar.google.com/scholar?cites=4804110826968085903&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:j3UKB1ihq0IJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4804110826968085903&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer","url":"https://science.sciencemag.org/content/348/6230/124.abstract","authors":["NA Rizvi","NA Rizvi MD Hellmann","NA Rizvi MD Hellmann A Snyder","NA Rizvi MD Hellmann A Snyder P Kvistborg…"],"year":2015,"numCitations":4359,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4993154/","citationUrl":"http://scholar.google.com/scholar?cites=6616874989748115658&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ylga177c01sJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6616874989748115658&hl=en&as_sdt=0,5","publication":"science.sciencemag.org"},{"title":"Safety and activity of anti–PD-L1 antibody in patients with advanced cancer","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1200694","authors":["JR Brahmer","JR Brahmer SS Tykodi","JR Brahmer SS Tykodi LQM Chow…"],"year":2012,"numCitations":5915,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1200694","citationUrl":"http://scholar.google.com/scholar?cites=13360512895833832804&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ZH0zFbETarkJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13360512895833832804&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"The blockade of immune checkpoints in cancer immunotherapy","url":"https://www.nature.com/articles/nrc3239/","authors":["DM Pardoll"],"year":2012,"numCitations":7766,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4856023/","citationUrl":"http://scholar.google.com/scholar?cites=11484971735372092127&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:31JBfvHQYp8J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11484971735372092127&hl=en&as_sdt=0,5","publication":"nature.com"},{"title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","url":"https://stm.sciencemag.org/content/4/127/127ra37.short","authors":["JM Taube","JM Taube RA Anders","JM Taube RA Anders GD Young","JM Taube RA Anders GD Young H Xu…"],"year":2012,"numCitations":1649,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568523/","citationUrl":"http://scholar.google.com/scholar?cites=17502950042268453215&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:X8nRLlT45vIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17502950042268453215&hl=en&as_sdt=0,5","publication":"stm.sciencemag.org"}]}